Official Press Release from Business Market Insights

Dialysis Catheters and Tubing Market Outlook: Rise in Demand of Vascular Access Products to Drive Market Growth to US$ 2.46 Billion by 2031

Published: June 12, 2025
Authored By: Krishna Sunthwal

Market Size (2024): US$ 1.72 Bn

Forecast Market Size (2031): US$ 2.46 Bn

CAGR (2025–2031): 5.24%

Primary Growth Drivers: High demand for vascular access products, Recurrent need for replacement and maintenance, Rising chronic kidney disease (CKD) incidence

Key Trends: Integration of Antimicrobial Materials in Catheters

Growth Opportunities: Growth in antimicrobial and heparin-coated catheter tech

Base Value (2024)

US$ 1.72 Bn

Projected (2031)

US$ 2.46 Bn

CAGR (2025-2031)

5.24%

As per the latest market research by Business Market Insights (BMI), the research report "Dialysis Catheters and Tubing Market Outlook Size and Forecast (2021–2031)" forecasts how the market is set to surge 43.2% by 2031 as growing demand of vascular access products reshapes dialysis catheters and tubing ecosystems. The report spotlights recurrent need of dialysis catheters and tubing in revolutionizing the global dialysis catheters and tubing landscape.

The report forecasts the market to expand from US$ 1.72 billion in 2024 to US$ 2.46 billion by 2031, registering a robust CAGR of 5.24% over the 2025–2031 period.

Patients with chronic kidney disease (CKD) or end-stage renal disease (ESRD) will require long-term, life-sustaining renal replacement therapy. As a result, dialysis is a continuum of care. Catheters, whether they are short or long-term, and the clinical tubing sets are required for each dialysis session and are considered consumables to be disposed of after each session. The demand for catheters and tubing is consistently sustained by the complications of infection and thrombosis that happen when catheter use is prolonged. This results in the need to remove catheters and replace them with new catheters in a near cycle of use. This is a sustainable and ongoing market.

Overview of report findings

Market Growth

The Dialysis Catheters and Tubing Market is projected to grow from US$ 1.72 billion in 2024 to US$ 2.46 billion by 2031, registering a compound annual growth rate (CAGR) of 5.24% between 2025 and 2031.

The recurrent need of dialysis catheters, rising chronic kidney disease incidence are key factors propelling market growth. The increasing demand of vascular access products globally is transforming the dialysis catheters and tubing landscape.

Rise in Chronic Kidney Disease Incidence

The underlying factor responsible for the growth of the dialysis catheters and tubing market is the rising incidence of Chronic Kidney Disease (CKD) that is being brought on by the sharper rise in the prevalence of such risk factors as diabetes and hypertension, and an aging population. CKD inevitably advances to End-stage Renal Disease (ESRD), which requires renal replacement therapy, usually through dialysis since there are limited numbers of kidney donors who can undergo transplantation as part of their treatment. An incrementally greater patient base, with the associated number of dialysis procedures taking place in hospitals, independent dialysis centres, and to a growing extent home care, directly provides a boosted demand for disposable supplies; in the form of dialysis catheters and their accompanying tubing. Innovations in catheter technology including antimicrobial coatings and better materials such as silicone, are supplementing this growth, as more manufacturers and healthcare systems respond to their patients' needs for safety and reduced levels of infections, as well as for better patient outcomes.

Increasing Demand of Vascular Access Products

The increasing utilization of vascular access products is the primary factor affecting the dialysis catheters and tubing market, as all patients undergoing the life-saving procedure of hemodialysis require vascular access through these products. In fact, vascular access is the vital "doorway" that allows blood to be drawn, filtered by the dialysis machine, and then returned to the patient. It is critical that patients are able to maintain reliable vascular access through a central venous catheter, arteriovenous fistula or graft, as these options will have a substantial influence on procedures of patients in the United States and worldwide with End-Stage Renal Disease (ESRD). Further, as the number of global patients with ESRD (and vascular access needs) continues to increase, the demand for vascular access will similarly increase. For many patients, the need for durable and reliable vascular access is essential. These patients may need vascular access for immediate or temporary, temporal purposes (such as while obtaining permanent vascular access) or may not be a candidate to receive permanent vascular access. Therefore, the demand for vascular access directly affects the market for dialysis catheters (that act as the first temporary access sites) and specialized tubing (that allows blood to flow between the patient and dialyzer-a device used to filter blood during hemodialysis). Escalating patient safety and controlling the risk of complications and condition such as blood clots and infections are leading to product advancements in catheters and tubing (such as, but not limited to, antimicrobial/silver coatings and use of cheaper and more biocompatible materials) which will also increase the current and future demand in the marketplace.

Geographic Insights

North America (mainly the USA) will continue to dominate the largest share of the market due to an established healthcare system, a strong prevalence of chronic kidney disease, advantageous reimbursement policies, and the presence of key medical device companies. Europe is in second place in terms of market share with a large patient population and attention to innovation and quality, while the Asia-Pacific (APAC) region is predicted to be the fastest growing market. The rapid growth in APAC is due to a huge and growing patient population, especially in China and India, improving healthcare systems, increasing healthcare spend, and Government efforts to increase access to dialysis treatment.

Market Segmentation

  • Based on Product, the market is segmented into Hemodialysis Catheters, Peritoneal Dialysis Catheters, Blood Tubing Sets, Catheter Accessories. The Hemodialysis Catheters segment dominated the market in 2024.
  • Based on Application, the market is segmented into Hemodialysis and Peritoneal Dialysis. The Hemodialysis segment dominated the market in 2024.
  • Based on End User, the market is segmented into In-Center Dialysis Settings and Home Care Settings. The In-Center Dialysis Settings dominated the market in 2024.

Competitive Strategy & Development

Key Players: The Dialysis Catheters and Tubing Market is populated by several key players, each contributing to its growth and innovation. Some prominent players are:

  1. Fresenius Medical Care AG & Co KGaA
  2. Baxter International Inc.
  3. DaVita Inc.
  4. Teleflex Inc
  5. B. Braun SE
  6. Terumo Corp

Trending Topics: Antimicrobial coatings, Minimally invasive insertion techniques, Personalized catheter, Home dialysis, Tunnelled and PICC catheters, Biodegradable tubing, Smart tubing, Disposable tubing, Braided tubing

Global Headlines

  • " Merit Medical Acquires AngioDynamics' Dialysis Catheter Portfolio - In June 2023, Merit Medical Systems completed a significant acquisition, purchasing a portfolio of dialysis catheter products and the BioSentry Biopsy Tract Sealant System from AngioDynamics for a cash consideration of US$100 million. The deal included several key brands, such as DuraFlow, DuraMax, and Trio-CT, with the acquisition of the BioFlo DuraMax Dialysis Catheter being a key highlight."
  • " U.S. FDA Approves CorMedix's Defence, a Catheter Lock Solution to Reduce Infections in Dialysis Patients - In November 2023, the U.S. Food and Drug Administration (FDA) granted approval to CorMedix's DefenCath, a catheter lock solution containing taurolidine and heparin. This approval marked a major advancement in addressing a critical issue in the dialysis patient population: catheter-related bloodstream infections (CRBSIs). DefenCath is the first and only FDA-approved antimicrobial catheter lock solution for this specific use, indicated to reduce the incidence of CRBSIs in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter."

Conclusion

The dialysis catheters and tubing market is experiencing strong growth, due to the convergence of a number of strong forces. The increased global prevalence of Chronic Kidney Disease (CKD), driven by an aging population and rising rates of diabetes and hypertension, is creating a sustained high demand for vascular access products. This demand is enabled by a constant need to replace and maintain catheters and tubing. While the high cost of treatment and limited reimbursement in developing economies will act as some restraints, the market is finding opportunities due to technological changes. Some trends are the addition of antimicrobial coatings to control infection, innovations in minimally invasive insertion techniques aimed at improving site and patient outcomes, and the need to use environmentally sustainable materials in response to environmental hazards related to single-use devices. The market will be shaped by single-use disposable catheter systems, low-cost tubing products, and portable devices that improve patient convenience, safety, and access to care at home.